S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   441.10 (+0.48%)
AAPL   179.04 (-0.95%)
MSFT   412.17 (-0.36%)
META   499.26 (+1.86%)
GOOGL   137.69 (-0.56%)
AMZN   177.02 (+0.15%)
TSLA   199.80 (-1.03%)
NVDA   802.68 (+1.46%)
NIO   5.75 (+0.00%)
AMD   199.25 (+3.49%)
BABA   74.41 (+0.51%)
T   17.00 (+0.41%)
F   12.53 (+0.72%)
MU   93.85 (+3.58%)
CGC   3.17 (-3.65%)
GE   158.15 (+0.80%)
DIS   111.71 (+0.12%)
AMC   4.34 (+0.46%)
PFE   26.66 (+0.38%)
PYPL   60.87 (+0.88%)
XOM   105.95 (+1.37%)
S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   441.10 (+0.48%)
AAPL   179.04 (-0.95%)
MSFT   412.17 (-0.36%)
META   499.26 (+1.86%)
GOOGL   137.69 (-0.56%)
AMZN   177.02 (+0.15%)
TSLA   199.80 (-1.03%)
NVDA   802.68 (+1.46%)
NIO   5.75 (+0.00%)
AMD   199.25 (+3.49%)
BABA   74.41 (+0.51%)
T   17.00 (+0.41%)
F   12.53 (+0.72%)
MU   93.85 (+3.58%)
CGC   3.17 (-3.65%)
GE   158.15 (+0.80%)
DIS   111.71 (+0.12%)
AMC   4.34 (+0.46%)
PFE   26.66 (+0.38%)
PYPL   60.87 (+0.88%)
XOM   105.95 (+1.37%)
S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   441.10 (+0.48%)
AAPL   179.04 (-0.95%)
MSFT   412.17 (-0.36%)
META   499.26 (+1.86%)
GOOGL   137.69 (-0.56%)
AMZN   177.02 (+0.15%)
TSLA   199.80 (-1.03%)
NVDA   802.68 (+1.46%)
NIO   5.75 (+0.00%)
AMD   199.25 (+3.49%)
BABA   74.41 (+0.51%)
T   17.00 (+0.41%)
F   12.53 (+0.72%)
MU   93.85 (+3.58%)
CGC   3.17 (-3.65%)
GE   158.15 (+0.80%)
DIS   111.71 (+0.12%)
AMC   4.34 (+0.46%)
PFE   26.66 (+0.38%)
PYPL   60.87 (+0.88%)
XOM   105.95 (+1.37%)
S&P 500   5,105.65 (+0.18%)
DOW   38,931.77 (-0.17%)
QQQ   441.10 (+0.48%)
AAPL   179.04 (-0.95%)
MSFT   412.17 (-0.36%)
META   499.26 (+1.86%)
GOOGL   137.69 (-0.56%)
AMZN   177.02 (+0.15%)
TSLA   199.80 (-1.03%)
NVDA   802.68 (+1.46%)
NIO   5.75 (+0.00%)
AMD   199.25 (+3.49%)
BABA   74.41 (+0.51%)
T   17.00 (+0.41%)
F   12.53 (+0.72%)
MU   93.85 (+3.58%)
CGC   3.17 (-3.65%)
GE   158.15 (+0.80%)
DIS   111.71 (+0.12%)
AMC   4.34 (+0.46%)
PFE   26.66 (+0.38%)
PYPL   60.87 (+0.88%)
XOM   105.95 (+1.37%)
NASDAQ:PAHC

Phibro Animal Health (PAHC) Stock Price, News & Analysis

$13.09
+0.16 (+1.24%)
(As of 10:02 AM ET)
Today's Range
$12.85
$13.18
50-Day Range
$10.63
$13.32
52-Week Range
$9.40
$16.52
Volume
10,387 shs
Average Volume
148,545 shs
Market Capitalization
$530.15 million
P/E Ratio
36.36
Dividend Yield
3.67%
Price Target
$15.33

Phibro Animal Health MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
18.6% Upside
$15.33 Price Target
Short Interest
Healthy
4.53% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-3.93
Upright™ Environmental Score
News Sentiment
0.99mentions of Phibro Animal Health in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.04%
From $1.12 to $1.21 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.38 out of 5 stars

Medical Sector

125th out of 957 stocks

Pharmaceutical Preparations Industry

46th out of 440 stocks


PAHC stock logo

About Phibro Animal Health Stock (NASDAQ:PAHC)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

PAHC Stock Price History

PAHC Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
What Makes Phibro (PAHC) a New Buy Stock
Richard Pzena Trims Stake in Phibro Animal Health Corp
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Q2 2024 Phibro Animal Health Corp Earnings Call
Phibro (PAHC) Q2 Earnings and Revenues Top, Margins Down
Phibro Animal Health Names Glenn David CFO
Phibro Animal Health Corp.
See More Headlines
Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 12/20 Dividend
11/28/2023
Dividend Payable
12/20/2023
Last Earnings
2/07/2024
Today
3/01/2024
Ex-Dividend for 3/27 Dividend
3/05/2024
Dividend Payable
3/27/2024
Next Earnings (Estimated)
5/01/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PAHC
Employees
1,920
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.33
High Stock Price Target
$21.00
Low Stock Price Target
$9.00
Potential Upside/Downside
+18.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$32.61 million
Pretax Margin
2.87%

Debt

Sales & Book Value

Annual Sales
$977.90 million
Cash Flow
$2.08 per share
Book Value
$6.69 per share

Miscellaneous

Free Float
20,227,000
Market Cap
$523.67 million
Optionable
Optionable
Beta
0.70
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Jack Clifford BendheimMr. Jack Clifford Bendheim (Age 77)
    Chairman, President & CEO
    Comp: $2.9M
  • Mr. Larry L. Miller (Age 60)
    Chief Operating Officer
    Comp: $774.91k
  • Mr. Daniel M. Bendheim (Age 52)
    Executive VP of Corporate Strategy & Director
    Comp: $548.18k
  • Mr. Rob Aukerman (Age 66)
    President of North America Region
    Comp: $619.27k
  • Mr. Glenn C. David (Age 51)
    Chief Financial Officer
  • Ms. Judith A. Weinstein (Age 55)
    Senior VP, General Counsel & Corporate Secretary
  • Ms. Lisa A. Escudero (Age 62)
    Senior Vice President of Human Resources
  • Mr. Jonathan Bendheim (Age 48)
    President of MACIE Region, GM of Israel Operations & Director
  • Mr. Ramon Fuenmayor
    President South America Region
  • Mr. Samson Li (Age 52)
    President of Asia Pacific Region














PAHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Phibro Animal Health stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" PAHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PAHC, but not buy additional shares or sell existing shares.
View PAHC analyst ratings
or view top-rated stocks.

What is Phibro Animal Health's stock price target for 2024?

3 brokerages have issued 12 month target prices for Phibro Animal Health's stock. Their PAHC share price targets range from $9.00 to $21.00. On average, they expect the company's stock price to reach $15.33 in the next year. This suggests a possible upside of 18.6% from the stock's current price.
View analysts price targets for PAHC
or view top-rated stocks among Wall Street analysts.

How have PAHC shares performed in 2024?

Phibro Animal Health's stock was trading at $11.58 on January 1st, 2024. Since then, PAHC shares have increased by 11.7% and is now trading at $12.93.
View the best growth stocks for 2024 here
.

When is Phibro Animal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 1st 2024.
View our PAHC earnings forecast
.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Co. (NASDAQ:PAHC) announced its earnings results on Wednesday, February, 7th. The company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.27 by $0.06. The company had revenue of $249.90 million for the quarter, compared to analysts' expectations of $242.91 million. Phibro Animal Health had a trailing twelve-month return on equity of 16.67% and a net margin of 1.51%.

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health declared a quarterly dividend on Tuesday, February 6th. Stockholders of record on Wednesday, March 6th will be paid a dividend of $0.12 per share on Wednesday, March 27th. This represents a $0.48 annualized dividend and a dividend yield of 3.71%. The ex-dividend date of this dividend is Tuesday, March 5th.
Read our dividend analysis for PAHC
.

Is Phibro Animal Health a good dividend stock?

Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 3.72%. The dividend payout ratio is 133.33%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, PAHC will have a dividend payout ratio of 39.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PAHC.

What ETFs hold Phibro Animal Health's stock?

ETFs with the largest weight of Phibro Animal Health (NASDAQ:PAHC) stock in their portfolio include Invesco S&P SmallCap High Dividend Low Volatility ETF (XSHD).iShares U.S. Pharmaceuticals ETF (IHE).

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health updated its FY 2024 earnings guidance on Wednesday, February, 7th. The company provided earnings per share (EPS) guidance of 1.040-1.160 for the period, compared to the consensus estimate of 1.070. The company issued revenue guidance of $980.0 million-$1.0 billion, compared to the consensus revenue estimate of $990.3 million.

What is Jack Bendheim's approval rating as Phibro Animal Health's CEO?

4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include Brandes Investment Partners LP (5.26%), Pzena Investment Management LLC (4.91%), Vanguard Group Inc. (4.44%), Dimensional Fund Advisors LP (1.92%), Hotchkis & Wiley Capital Management LLC (1.34%) and Smith Graham & Co. Investment Advisors LP (1.11%).
View institutional ownership trends
.

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PAHC) was last updated on 3/1/2024 by MarketBeat.com Staff